Physician profile
Thomas P Bocchini
NPI 1194765578
$5,612.20
in general payments reported to CMS, 2019-2025
13 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,480 · 2020: $37.22 · 2022: $144 · 2023: $267 · 2024: $447 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,699.69 | 2019 | |
| Trisalus Life Sciences, INC. | $300.27 | 2022-2023 | Trinav Infusion System |
| Boston Scientific Corporation | $260.14 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $240.13 | 2019 | |
| Penumbra, INC. | $211.59 | 2019-2024 | Indigo System |
| Cordis US Corp. | $197.19 | 2023-2025 | S.M.A.R.T., Mynx Control, Outback Elite |
| W. L. Gore & Associates, INC. | $187.59 | 2019-2025 | Viatorr Endoprosthesis |
| Angiodynamics, INC. | $154.04 | 2024 | Alphavac |
| Ekos Corporation | $107.34 | 2019 | |
| Covidien LP | $105.94 | 2019-2020 | |
| Terumo Medical Corporation | $95.39 | 2019 | |
| Intuitive Surgical, INC. | $36.01 | 2019 | |
| Convatec INC. | $16.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bocchini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.